|
|
Cell therapy for the treatment of reproductive diseases and infertility: an overview from the mechanism to the clinic alongside diagnostic methods |
Kosar Babaei1, Mohsen Aziminezhad1,2, Seyedeh Elham Norollahi3, Sogand Vahidi4, Ali Akbar Samadani5() |
1. Non-Communicable Disease Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran 2. UMR INSERM U 1122, IGE-PCV, Interactions Gène-Environment En Physiopathologie Cardiovascular Université De Lorraine, Nancy, France 3. Cancer Research Center and Department of Immunology, Semnan University of Medical Sciences, Semnan, Iran 4. Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran 5. Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran |
|
|
Abstract Infertility is experienced by 8%–12% of adults in their reproductive period globally and has become a prevalent concern. Besides routine therapeutic methods, stem cells are rapidly being examined as viable alternative therapies in regenerative medicine and translational investigation. Remarkable progress has been made in understanding the biology and purpose of stem cells. The affected pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSCs) are further studied for their possible use in reproductive medicine, particularly for infertility induced by premature ovarian insufficiency and azoospermia. Accordingly, this study discusses current developments in the use of some kinds of MSCs such as adipose-derived stem cells, bone marrow stromal cells, umbilical cord MSCs, and menstrual blood MSCs. These methods have been used to manage ovarian and uterine disorders, and each technique presents a novel method for the therapy of infertility.
|
Keywords
infertility
stem cell therapy
mesenchymal stem cells
pluripotent stem cells
|
Corresponding Author(s):
Ali Akbar Samadani
|
Just Accepted Date: 12 October 2022
Online First Date: 22 December 2022
Issue Date: 16 January 2023
|
|
1 |
MG Hull, CM Glazener, NJ Kelly, DI Conway, PA Foster, RA Hinton, C Coulson, PA Lambert, EM Watt, KM Desai. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291(6510): 1693–1697
https://doi.org/10.1136/bmj.291.6510.1693
pmid: 3935248
|
2 |
A Deroux, C Dumestre-Perard, C Dunand-Faure, L Bouillet, P Hoffmann. Female infertility and serum auto-antibodies: a systematic review. Clin Rev Allergy Immunol 2017; 53(1): 78–86
https://doi.org/10.1007/s12016-016-8586-z
pmid: 27628237
|
3 |
L Holmberg, OE Iversen, CM Rudenstam, M Hammar, E Kumpulainen, J Jaskiewicz, J Jassem, D Dobaczewska, HE Fjosne, O Peralta, R Arriagada, M Holmqvist, J; HABITS Study Group Maenpaa. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst 2008; 100(7): 475–482
https://doi.org/10.1093/jnci/djn058
pmid: 18364505
|
4 |
RFM Vermeulen, CM Korse, GG Kenter, MMA Brood-van Zanten, MV Beurden. Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines. Climacteric 2019; 22(4): 352–360
https://doi.org/10.1080/13697137.2019.1582622
pmid: 30905183
|
5 |
Committee of American Society for Reproductive Medicine Practice. Multiple gestation associated with infertility therapy: an American Society for Reproductive Medicine Practice Committee opinion. Fertil Steril 2012; 97(4): 825–834
https://doi.org/10.1016/j.fertnstert.2011.11.048
pmid: 22192352
|
6 |
B Blum, N Benvenisty. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 2008; 100: 133–158
https://doi.org/10.1016/S0065-230X(08)00005-5
pmid: 18620095
|
7 |
M Dominici, Blanc K Le, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, Dj Prockop, E Horwitz. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315–317
https://doi.org/10.1080/14653240600855905
pmid: 16923606
|
8 |
HK Salem, C Thiemermann. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010; 28(3): 585–596
https://doi.org/10.1002/stem.269
pmid: 19967788
|
9 |
M Körbling, P Anderlini. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?. Blood 2001; 98(10): 2900–2908
https://doi.org/10.1182/blood.V98.10.2900
pmid: 11698269
|
10 |
Anker PS In’t, SA Scherjon, der Keur C Kleijburg-van, Groot-Swings GM de, FH Claas, WE Fibbe, HH Kanhai. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004; 22(7): 1338–1345
https://doi.org/10.1634/stemcells.2004-0058
pmid: 15579651
|
11 |
KR Hansen, AL He, AK Styer, RA Wild, S Butts, L Engmann, MP Diamond, RS Legro, C Coutifaris, R Alvero, RD Robinson, P Casson, GM Christman, H Huang, N Santoro, E Eisenberg, H; Eunice Kennedy Shriver National Institute of Child Health Zhang, Development Reproductive Medicine Network Human. Predictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination. Fertil Steril 2016; 105(6): 1575–1583.e2
https://doi.org/10.1016/j.fertnstert.2016.02.020
pmid: 26949110
|
12 |
OA Asemota, P Klatsky. Access to infertility care in the developing world: the family promotion gap. Semin Reprod Med 2015; 33(1): 17–22
https://doi.org/10.1055/s-0034-1395274
pmid: 25565507
|
13 |
S Mourad, J Brown, C Farquhar. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database Syst Rev 2017; 1(1): CD012103
https://doi.org/10.1002/14651858.CD012103.pub2
pmid: 28111738
|
14 |
M Kathrins, C Niederberger. Diagnosis and treatment of infertility-related male hormonal dysfunction. Nat Rev Urol 2016; 13(6): 309–323
https://doi.org/10.1038/nrurol.2016.62
pmid: 27091665
|
15 |
RP Smith, LI Lipshultz, JR Kovac. Stem cells, gene therapy, and advanced medical management hold promise in the treatment of male infertility. Asian J Androl 2016; 18(3): 364
https://doi.org/10.4103/1008-682X.179249
pmid: 27056350
|
16 |
D Chen, JJ Gell, Y Tao, E Sosa, AT Clark. Modeling human infertility with pluripotent stem cells. Stem Cell Res (Amst) 2017; 21: 187–192
https://doi.org/10.1016/j.scr.2017.04.005
pmid: 28431857
|
17 |
V Volarevic, S Bojic, J Nurkovic, A Volarevic, B Ljujic, N Arsenijevic, M Lako, M Stojkovic. Stem cells as new agents for the treatment of infertility: current and future perspectives and challenges. Biomed Res Int 2014; 2014: 507234
https://doi.org/10.1155/2014/507234
pmid: 24826378
|
18 |
K Yoshinaga, S Nishikawa, M Ogawa, S Hayashi, T Kunisada, T Fujimoto, S Nishikawa. Role of c-kit in mouse spermatogenesis: identification of spermatogonia as a specific site of c-kit expression and function. Development 1991; 113(2): 689–699
https://doi.org/10.1242/dev.113.2.689
pmid: 1723681
|
19 |
K Kawamura, N Kawamura, AJ Hsueh. Activation of dormant follicles: a new treatment for premature ovarian failure?. Curr Opin Obstet Gynecol 2016; 28(3): 217–222
https://doi.org/10.1097/GCO.0000000000000268
pmid: 27022685
|
20 |
N Rozwadowska, D Fiszer, P Jedrzejczak, W Kosicki, M Kurpisz. Interleukin-1 superfamily genes expression in normal or impaired human spermatogenesis. Genes Immun 2007; 8(2): 100–107
https://doi.org/10.1038/sj.gene.6364356
pmid: 17215863
|
21 |
M Huleihel, E Lunenfeld. Regulation of spermatogenesis by paracrine/autocrine testicular factors. Asian J Androl 2004; 6(3): 259–268
pmid: 15273877
|
22 |
CE Naylor, C Bagnéris, PG DeCaen, A Sula, A Scaglione, DE Clapham, BA Wallace. Molecular basis of ion permeability in a voltage-gated sodium channel. EMBO J 2016; 35(8): 820–830
https://doi.org/10.15252/embj.201593285
pmid: 26873592
|
23 |
F Fang, Z Li, Q Zhao, H Li, C Xiong. Human induced pluripotent stem cells and male infertility: an overview of current progress and perspectives. Hum Reprod 2018; 33(2): 188–195
https://doi.org/10.1093/humrep/dex369
pmid: 29315416
|
24 |
J Hou, S Yang, H Yang, Y Liu, Y Liu, Y Hai, Z Chen, Y Guo, Y Gong, WQ Gao, Z Li, Z He. Generation of male differentiated germ cells from various types of stem cells. Reproduction 2014; 147(6): R179–R188
https://doi.org/10.1530/REP-13-0649
pmid: 24534952
|
25 |
C Eguizabal, N Montserrat, R Vassena, M Barragan, E Garreta, L Garcia-Quevedo, F Vidal, A Giorgetti, A Veiga, JC Izpisua Belmonte. Complete meiosis from human induced pluripotent stem cells. Stem Cells 2011; 29(8): 1186–1195
https://doi.org/10.1002/stem.672
pmid: 21681858
|
26 |
C Ramathal, J Durruthy-Durruthy, M Sukhwani, JE Arakaki, PJ Turek, KE Orwig, RA Reijo Pera. Fate of iPSCs derived from azoospermic and fertile men following xenotransplantation to murine seminiferous tubules. Cell Rep 2014; 7(4): 1284–1297
https://doi.org/10.1016/j.celrep.2014.03.067
pmid: 24794432
|
27 |
N Irie, L Weinberger, WW Tang, T Kobayashi, S Viukov, YS Manor, S Dietmann, JH Hanna, MA Surani. SOX17 is a critical specifier of human primordial germ cell fate. Cell 2015; 160(1–2): 253–268
https://doi.org/10.1016/j.cell.2014.12.013
pmid: 25543152
|
28 |
K Sasaki, S Yokobayashi, T Nakamura, I Okamoto, Y Yabuta, K Kurimoto, H Ohta, Y Moritoki, C Iwatani, H Tsuchiya, S Nakamura, K Sekiguchi, T Sakuma, T Yamamoto, T Mori, K Woltjen, M Nakagawa, T Yamamoto, K Takahashi, S Yamanaka, M Saitou. Robust in vitro induction of human germ cell fate from pluripotent stem cells. Cell Stem Cell 2015; 17(2): 178–194
https://doi.org/10.1016/j.stem.2015.06.014
pmid: 26189426
|
29 |
CA 4th Easley, BT Phillips, MM McGuire, JM Barringer, H Valli, BP Hermann, CR Simerly, A Rajkovic, T Miki, KE Orwig, GP Schatten. Direct differentiation of human pluripotent stem cells into haploid spermatogenic cells. Cell Rep 2012; 2(3): 440–446
https://doi.org/10.1016/j.celrep.2012.07.015
pmid: 22921399
|
30 |
JJ Gell, AT Clark. Restoring fertility with human induced pluripotent stem cells: are we there yet?. Cell Stem Cell 2018; 23(6): 777–779
https://doi.org/10.1016/j.stem.2018.11.003
pmid: 30526878
|
31 |
F Sugawa, MJ Araúzo-Bravo, J Yoon, KP Kim, S Aramaki, G Wu, M Stehling, OE Psathaki, K Hübner, HR Schöler. Human primordial germ cell commitment in vitro associates with a unique PRDM14 expression profile. EMBO J 2015; 34(8): 1009–1024
https://doi.org/10.15252/embj.201488049
pmid: 25750208
|
32 |
HN Sallam, SS Sadek, AF Agameya. Assisted hatching—a meta-analysis of randomized controlled trials. J Assist Reprod Genet 2003; 20(8): 332–342
https://doi.org/10.1023/A:1024865725713
pmid: 12948097
|
33 |
D Bharti, SJ Jang, SY Lee, SL Lee, GJ Rho. In vitro generation of oocyte like cells and their in vivo efficacy: how far we have been succeeded. Cells 2020; 9(3): 557
https://doi.org/10.3390/cells9030557
pmid: 32120836
|
34 |
P Wu, G Deng, X Sai, H Guo, H Huang, P Zhu. Maturation strategies and limitations of induced pluripotent stem cell-derived cardiomyocytes. Biosci Rep 2021; 41(6): BSR20200833
https://doi.org/10.1042/BSR20200833
pmid: 33057659
|
35 |
AS Lee, C Tang, MS Rao, IL Weissman, JC Wu. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med 2013; 19(8): 998–1004
https://doi.org/10.1038/nm.3267
pmid: 23921754
|
36 |
S Fernandez Tde, C de Souza Fernandez, AL Mencalha. Human induced pluripotent stem cells from basic research to potential clinical applications in cancer. Biomed Res Int 2013; 2013: 430290
https://doi.org/10.1155/2013/430290
pmid: 24288679
|
37 |
AA Samadani, A Keymoradzdeh, S Shams, A Soleymanpour, A Rashidy-Pour, H Hashemian, S Vahidi, SE Norollahi. CAR T-cells profiling in carcinogenesis and tumorigenesis: an overview of CAR T-cells cancer therapy. Int Immunopharmacol 2021; 90: 107201
https://doi.org/10.1016/j.intimp.2020.107201
pmid: 33249047
|
38 |
A Naji, N Rouas-Freiss, A Durrbach, ED Carosella, L Sensébé, F Deschaseaux. Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Stem Cells 2013; 31(11): 2296–2303
https://doi.org/10.1002/stem.1494
pmid: 23922260
|
39 |
A Trounson, C McDonald. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell 2015; 17(1): 11–22
https://doi.org/10.1016/j.stem.2015.06.007
pmid: 26140604
|
40 |
N Desai, P Rambhia, A Gishto. Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems. Reprod Biol Endocrinol 2015; 13(1): 9
https://doi.org/10.1186/s12958-015-0005-4
pmid: 25890180
|
41 |
J Kehler, K Hübner, S Garrett, HR Schöler. Generating oocytes and sperm from embryonic stem cells. Semin Reprod Med 2005; 23(3): 222–233
https://doi.org/10.1055/s-2005-872450
pmid: 16059828
|
42 |
Y Yuan, Q Zhou, H Wan, B Shen, X Wang, M Wang, C Feng, M Xie, T Gu, T Zhou, R Fu, X Huang, Q Zhou, J Sha, XY Zhao. Generation of fertile offspring from Kit(w)/Kit(wv) mice through differentiation of gene corrected nuclear transfer embryonic stem cells. Cell Res 2015; 25(7): 851–863
https://doi.org/10.1038/cr.2015.74
pmid: 26088417
|
43 |
J Wang, C Liu, M Fujino, G Tong, Q Zhang, XK Li, H Yan. Stem cells as a resource for treatment of infertility-related diseases. Curr Mol Med 2019; 19(8): 539–546
https://doi.org/10.2174/1566524019666190709172636
pmid: 31288721
|
44 |
K Kita, T Watanabe, K Ohsaka, H Hayashi, Y Kubota, Y Nagashima, I Aoki, H Taniguchi, T Noce, K Inoue, H Miki, N Ogonuki, H Tanaka, A Ogura, T Ogawa. Production of functional spermatids from mouse germline stem cells in ectopically reconstituted seminiferous tubules. Biol Reprod 2007; 76(2): 211–217
https://doi.org/10.1095/biolreprod.106.056895
pmid: 17065598
|
45 |
H Kubota, RL Brinster. Spermatogonial stem cells. Biol Reprod 2018; 99(1): 52–74
https://doi.org/10.1093/biolre/ioy077
pmid: 29617903
|
46 |
DM De Kretser, HW Baker. Infertility in men: recent advances and continuing controversies. J Clin Endocrinol Metab 1999; 84(10): 3443–3450
pmid: 10522977
|
47 |
M Kanatsu-Shinohara, J Lee, K Inoue, N Ogonuki, H Miki, S Toyokuni, M Ikawa, T Nakamura, A Ogura, T Shinohara. Pluripotency of a single spermatogonial stem cell in mice. Biol Reprod 2008; 78(4): 681–687
https://doi.org/10.1095/biolreprod.107.066068
pmid: 18199882
|
48 |
DJ McLean. Spermatogonial stem cell transplantation and testicular function. Cell Tissue Res 2005; 322(1): 21–31
https://doi.org/10.1007/s00441-005-0009-z
pmid: 16047158
|
49 |
K Guan, K Nayernia, LS Maier, S Wagner, R Dressel, JH Lee, J Nolte, F Wolf, M Li, W Engel, G Hasenfuss. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006; 440(7088): 1199–1203
https://doi.org/10.1038/nature04697
pmid: 16565704
|
50 |
FK Hamra, N Schultz, KM Chapman, DM Grellhesl, JT Cronkhite, RE Hammer, DL Garbers. Defining the spermatogonial stem cell. Dev Biol 2004; 269(2): 393–410
https://doi.org/10.1016/j.ydbio.2004.01.027
pmid: 15110708
|
51 |
F Izadyar, J Wong, C Maki, J Pacchiarotti, T Ramos, K Howerton, C Yuen, S Greilach, HH Zhao, M Chow, YC Chow, J Rao, J Barritt, N Bar-Chama, A Copperman. Identification and characterization of repopulating spermatogonial stem cells from the adult human testis. Hum Reprod 2011; 26(6): 1296–1306
https://doi.org/10.1093/humrep/der026
pmid: 21349855
|
52 |
BP Hermann, M Sukhwani, F Winkler, JN Pascarella, KA Peters, Y Sheng, H Valli, M Rodriguez, M Ezzelarab, G Dargo, K Peterson, K Masterson, C Ramsey, T Ward, M Lienesch, A Volk, DK Cooper, AW Thomson, JE Kiss, MC Penedo, GP Schatten, S Mitalipov, KE Orwig. Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm. Cell Stem Cell 2012; 11(5): 715–726
https://doi.org/10.1016/j.stem.2012.07.017
pmid: 23122294
|
53 |
J Koubova, DB Menke, Q Zhou, B Capel, MD Griswold, DC Page. Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc Natl Acad Sci USA 2006; 103(8): 2474–2479
https://doi.org/10.1073/pnas.0510813103
pmid: 16461896
|
54 |
MD Griswold. The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol 1998; 9(4): 411–416
https://doi.org/10.1006/scdb.1998.0203
pmid: 9813187
|
55 |
AG Byskov, M Fenger, L Westergaard, CY Andersen. Forskolin and the meiosis inducing substance synergistically initiate meiosis in fetal male germ cells. Mol Reprod Dev 1993; 34(1): 47–52
https://doi.org/10.1002/mrd.1080340108
pmid: 8418816
|
56 |
Y Zhu, HL Hu, P Li, S Yang, W Zhang, H Ding, RH Tian, Y Ning, LL Zhang, XZ Guo, ZP Shi, Z Li, Z He. Generation of male germ cells from induced pluripotent stem cells (iPS cells): an in vitro and in vivo study. Asian J Androl 2012; 14(4): 574–579
https://doi.org/10.1038/aja.2012.3
pmid: 22504877
|
57 |
CA 4th Easley, CR Simerly, G Schatten. Stem cell therapeutic possibilities: future therapeutic options for male-factor and female-factor infertility?. Reprod Biomed Online 2013; 27(1): 75–80
https://doi.org/10.1016/j.rbmo.2013.03.003
pmid: 23664220
|
58 |
J Johnson, J Canning, T Kaneko, JK Pru, JL Tilly. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004; 428(6979): 145–150
https://doi.org/10.1038/nature02316
pmid: 15014492
|
59 |
YA White, DC Woods, Y Takai, O Ishihara, H Seki, JL Tilly. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med 2012; 18(3): 413–421
https://doi.org/10.1038/nm.2669
pmid: 22366948
|
60 |
CE Dunlop, EE Telfer, RA Anderson. Ovarian stem cells—potential roles in infertility treatment and fertility preservation. Maturitas 2013; 76(3): 279–283
https://doi.org/10.1016/j.maturitas.2013.04.017
pmid: 23693139
|
61 |
J Oatley, PA Hunt. Of mice and (wo)men: purified oogonial stem cells from mouse and human ovaries. Biol Reprod 2012; 86(6): 196
https://doi.org/10.1095/biolreprod.112.100297
pmid: 22402962
|
62 |
Y Niikura, T Niikura, JL Tilly. Aged mouse ovaries possess rare premeiotic germ cells that can generate oocytes following transplantation into a young host environment. Aging (Albany NY) 2009; 1(12): 971–978
https://doi.org/10.18632/aging.100105
pmid: 20157580
|
63 |
RA Anderson, WHB Wallace. Fertility preservation in girls and young women. Clin Endocrinol (Oxf) 2011; 75(4): 409–419
https://doi.org/10.1111/j.1365-2265.2011.04100.x
pmid: 21575025
|
64 |
VA Prianishnikov. On the concept of stem cell and a model of functional-morphological structure of the endometrium. Contraception 1978; 18(3): 213–223
https://doi.org/10.1016/S0010-7824(78)80015-8
pmid: 569035
|
65 |
RW Chan, KE Schwab, CE Gargett. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 2004; 70(6): 1738–1750
https://doi.org/10.1095/biolreprod.103.024109
pmid: 14766732
|
66 |
CE Gargett, KE Schwab, RM Zillwood, HP Nguyen, D Wu. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod 2009; 80(6): 1136–1145
https://doi.org/10.1095/biolreprod.108.075226
pmid: 19228591
|
67 |
Miguel-Gómez L de, S López-Martínez, E Francés-Herrero, A Rodríguez-Eguren, A Pellicer, I Cervelló. Stem cells and the endometrium: from the discovery of adult stem cells to pre-clinical models. Cells 2021; 10(3): 595
https://doi.org/10.3390/cells10030595
pmid: 33800355
|
68 |
A Akbar Samadani, A Keymoradzdeh, S Shams, A Soleymanpour, S Elham Norollahi, S Vahidi, A Rashidy-Pour, A Ashraf, E Mirzajani, K Khanaki, M Rahbar Taramsari, S Samimian, A Najafzadeh. Mechanisms of cancer stem cell therapy. Clin Chim Acta 2020; 510: 581–592
https://doi.org/10.1016/j.cca.2020.08.016
pmid: 32791136
|
69 |
S Rahimi, AM Roushandeh, A Ebrahimi, AA Samadani, Y Kuwahara, MH Roudkenar. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells. Life Sci 2019; 231: 116586
https://doi.org/10.1016/j.lfs.2019.116586
pmid: 31220528
|
70 |
T Lapidot, I Petit. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002; 30(9): 973–981
https://doi.org/10.1016/S0301-472X(02)00883-4
pmid: 12225788
|
71 |
R Azizi, L Aghebati-Maleki, M Nouri, F Marofi, S Negargar, M Yousefi. Stem cell therapy in Asherman syndrome and thin endometrium: stem cell-based therapy. Biomed Pharmacother 2018; 102: 333–343
https://doi.org/10.1016/j.biopha.2018.03.091
pmid: 29571018
|
72 |
K Kato, M Yoshimoto, K Kato, S Adachi, A Yamayoshi, T Arima, K Asanoma, S Kyo, T Nakahata, N Wake. Characterization of side-population cells in human normal endometrium. Hum Reprod 2007; 22(5): 1214–1223
https://doi.org/10.1093/humrep/del514
pmid: 17283036
|
73 |
X Meng, TE Ichim, J Zhong, A Rogers, Z Yin, J Jackson, H Wang, W Ge, V Bogin, KW Chan, B Thébaud, NH Riordan. Endometrial regenerative cells: a novel stem cell population. J Transl Med 2007; 5(1): 57
https://doi.org/10.1186/1479-5876-5-57
pmid: 18005405
|
74 |
CE Gargett, PA Rogers. Human endometrial angiogenesis. Reproduction 2001; 121(2): 181–186
https://doi.org/10.1530/rep.0.1210181
pmid: 11226042
|
75 |
A Numao, K Hosono, T Suzuki, I Hayashi, S Uematsu, S Akira, Y Ogino, H Kawauchi, N Unno, M Majima. The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model. Biomed Pharmacother 2011; 65(1): 77–84
https://doi.org/10.1016/j.biopha.2010.12.008
pmid: 21247731
|
76 |
EF Wolff, L Mutlu, EE Massasa, JD Elsworth, Redmond D Jr Eugene, HS Taylor. Endometrial stem cell transplantation in MPTP-exposed primates: an alternative cell source for treatment of Parkinson’s disease. J Cell Mol Med 2015; 19(1): 249–256
https://doi.org/10.1111/jcmm.12433
pmid: 25283241
|
77 |
X Santamaria, EE Massasa, Y Feng, E Wolff, HS Taylor. Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes. Mol Ther 2011; 19(11): 2065–2071
https://doi.org/10.1038/mt.2011.173
pmid: 21878900
|
78 |
Q Xie, X Xiong, N Xiao, K He, M Chen, J Peng, X Su, H Mei, Y Dai, D Wei, G Lin, L Cheng. Mesenchymal stem cells alleviate DHEA-induced polycystic ovary syndrome (PCOS) by inhibiting inflammation in mice. Stem Cells Int 2019; 2019: 9782373
https://doi.org/10.1155/2019/9782373
pmid: 31611920
|
79 |
SA Mohamed, S Shalaby, S Brakta, L Elam, A Elsharoud, A Al-Hendy. Umbilical cord blood mesenchymal stem cells as an infertility treatment for chemotherapy induced premature ovarian insufficiency. Biomedicines 2019; 7(1): 7
https://doi.org/10.3390/biomedicines7010007
pmid: 30669278
|
80 |
D Song, Y Zhong, C Qian, Q Zou, J Ou, Y Shi, L Gao, G Wang, Z Liu, H Li, H Ding, H Wu, F Wang, J Wang, H Li. Human umbilical cord mesenchymal stem cells therapy in cyclophosphamide-induced premature ovarian failure rat model. Biomed Res Int 2016; 2016: 2517514
https://doi.org/10.1155/2016/2517514
pmid: 27047962
|
81 |
AK Elfayomy, SM Almasry, SA El-Tarhouny, MA Eldomiaty. Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: possible direct and indirect effects. Tissue Cell 2016; 48(4): 370–382
https://doi.org/10.1016/j.tice.2016.05.001
pmid: 27233913
|
82 |
C Zhang. The roles of different stem cells in premature ovarian failure. Curr Stem Cell Res Ther 2020; 15(6): 473–481
https://doi.org/10.2174/1574888X14666190314123006
pmid: 30868961
|
83 |
Q Shi, J Gao, Y Jiang, B Sun, W Lu, M Su, Y Xu, X Yang, Y Zhang. Differentiation of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells into endometrial cells. Stem Cell Res Ther 2017; 8(1): 246
https://doi.org/10.1186/s13287-017-0700-5
pmid: 29096715
|
84 |
L Zhang, Y Li, CY Guan, S Tian, XD Lv, JH Li, X Ma, HF Xia. Therapeutic effect of human umbilical cord-derived mesenchymal stem cells on injured rat endometrium during its chronic phase. Stem Cell Res Ther 2018; 9(1): 36
https://doi.org/10.1186/s13287-018-0777-5
pmid: 29433563
|
85 |
L Xu, L Ding, L Wang, Y Cao, H Zhu, J Lu, X Li, T Song, Y Hu, J Dai. Umbilical cord-derived mesenchymal stem cells on scaffolds facilitate collagen degradation via upregulation of MMP-9 in rat uterine scars. Stem Cell Res Ther 2017; 8(1): 84
https://doi.org/10.1186/s13287-017-0535-0
pmid: 28420433
|
86 |
L Ding, G Yan, B Wang, L Xu, Y Gu, T Ru, X Cui, L Lei, J Liu, X Sheng, B Wang, C Zhang, Y Yang, R Jiang, J Zhou, N Kong, F Lu, H Zhou, Y Zhao, B Chen, Y Hu, J Dai, H Sun. Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility. Sci China Life Sci 2018; 61(12): 1554–1565
https://doi.org/10.1007/s11427-017-9272-2
pmid: 29546669
|
87 |
X Yang, M Zhang, Y Zhang, W Li, B Yang. Mesenchymal stem cells derived from Wharton jelly of the human umbilical cord ameliorate damage to human endometrial stromal cells. Fertil Steril 2011; 96(4): 1029–1036
https://doi.org/10.1016/j.fertnstert.2011.07.005
pmid: 21802667
|
88 |
SA Steigman, A Ahmed, RM Shanti, RS Tuan, C Valim, DO Fauza. Sternal repair with bone grafts engineered from amniotic mesenchymal stem cells. J Pediatr Surg 2009; 44(6): 1120–1126
https://doi.org/10.1016/j.jpedsurg.2009.02.038
pmid: 19524727
|
89 |
SM Kunisaki, JR Fuchs, A Kaviani, JT Oh, DA LaVan, JP Vacanti, JM Wilson, DO Fauza. Diaphragmatic repair through fetal tissue engineering: a comparison between mesenchymal amniocyte- and myoblast-based constructs. J Pediatr Surg 2006; 41(1): 34–39
https://doi.org/10.1016/j.jpedsurg.2005.10.011
pmid: 16410104
|
90 |
GY Xiao, IH Liu, CC Cheng, CC Chang, YH Lee, WT Cheng, SC Wu. Amniotic fluid stem cells prevent follicle atresia and rescue fertility of mice with premature ovarian failure induced by chemotherapy. PLoS One 2014; 9(9): e106538
https://doi.org/10.1371/journal.pone.0106538
pmid: 25198549
|
91 |
T Liu, Y Huang, L Guo, W Cheng, G Zou. CD44+/CD105+ human amniotic fluid mesenchymal stem cells survive and proliferate in the ovary long-term in a mouse model of chemotherapy-induced premature ovarian failure. Int J Med Sci 2012; 9(7): 592–602
https://doi.org/10.7150/ijms.4841
pmid: 23028242
|
92 |
RH Lee, B Kim, I Choi, H Kim, HS Choi, K Suh, YC Bae, JS Jung. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004; 14(4–6): 311–324
https://doi.org/10.1159/000080341
pmid: 15319535
|
93 |
LL Damous, JS Nakamuta, AE Carvalho, KC Carvalho, JM Jr Soares, MJ Simões, JE Krieger, EC Baracat. Does adipose tissue-derived stem cell therapy improve graft quality in freshly grafted ovaries?. Reprod Biol Endocrinol 2015; 13(1): 108
https://doi.org/10.1186/s12958-015-0104-2
pmid: 26394676
|
94 |
M Sun, S Wang, Y Li, L Yu, F Gu, C Wang, Y Yao. Adipose-derived stem cells improved mouse ovary function after chemotherapy-induced ovary failure. Stem Cell Res Ther 2013; 4(4): 80
https://doi.org/10.1186/scrt231
pmid: 23838374
|
95 |
S Kilic, B Yuksel, F Pinarli, A Albayrak, B Boztok, T Delibasi. Effect of stem cell application on Asherman syndrome, an experimental rat model. J Assist Reprod Genet 2014; 31(8): 975–982
https://doi.org/10.1007/s10815-014-0268-2
pmid: 24974357
|
96 |
L Ling, X Feng, T Wei, Y Wang, Y Wang, Z Wang, D Tang, Y Luo, Z Xiong. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism. Stem Cell Res Ther 2019; 10(1): 46
https://doi.org/10.1186/s13287-019-1136-x
pmid: 30683144
|
97 |
X Feng, L Ling, W Zhang, X Liu, Y Wang, Y Luo, Z Xiong. Effects of human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation in situ on primary ovarian insufficiency in SD rats. Reprod Sci 2020; 27(7): 1502–1512
https://doi.org/10.1007/s43032-020-00147-0
pmid: 31953773
|
98 |
N Yin, Y Wang, X Lu, R Liu, L Zhang, W Zhao, W Yuan, Q Luo, H Wu, X Luan, H Zhang. hPMSC transplantation restoring ovarian function in premature ovarian failure mice is associated with change of Th17/Tc17 and Th17/Treg cell ratios through the PI3K/Akt signal pathway. Stem Cell Res Ther 2018; 9(1): 37
https://doi.org/10.1186/s13287-018-0772-x
pmid: 29444704
|
99 |
H Li, W Zhao, L Wang, Q Luo, N Yin, X Lu, Y Hou, J Cui, H Zhang. Human placenta-derived mesenchymal stem cells inhibit apoptosis of granulosa cells induced by IRE1α pathway in autoimmune POF mice. Cell Biol Int 2019; 43(8): 899–909
https://doi.org/10.1002/cbin.11165
pmid: 31081266
|
100 |
TH Kim, JH Choi, Y Jun, SM Lim, S Park, JY Paek, SH Lee, JY Hwang, GJ Kim. 3D-cultured human placenta-derived mesenchymal stem cell spheroids enhance ovary function by inducing folliculogenesis. Sci Rep 2018; 8(1): 15313
https://doi.org/10.1038/s41598-018-33575-9
pmid: 30333505
|
101 |
HM Qu, LP Qu, XZ Pan, LS Mu. Upregulated miR-222 targets BCL2L11 and promotes apoptosis of mesenchymal stem cells in preeclampsia patients in response to severe hypoxia. Int J Clin Exp Pathol 2018; 11(1): 110–119
pmid: 31938092
|
102 |
MD Manshadi, S Navid, Y Hoshino, E Daneshi, P Noory, M Abbasi. The effects of human menstrual blood stem cells-derived granulosa cells on ovarian follicle formation in a rat model of premature ovarian failure. Microsc Res Tech 2019; 82(6): 635–642
https://doi.org/10.1002/jemt.23120
pmid: 30582244
|
103 |
A Domnina, P Novikova, J Obidina, I Fridlyanskaya, L Alekseenko, I Kozhukharova, O Lyublinskaya, V Zenin, N Nikolsky. Human mesenchymal stem cells in spheroids improve fertility in model animals with damaged endometrium. Stem Cell Res Ther 2018; 9(1): 50
https://doi.org/10.1186/s13287-018-0801-9
pmid: 29482664
|
104 |
SX Zheng, J Wang, XL Wang, A Ali, LM Wu, YS Liu. Feasibility analysis of treating severe intrauterine adhesions by transplanting menstrual blood-derived stem cells. Int J Mol Med 2018; 41(4): 2201–2212
https://doi.org/10.3892/ijmm.2018.3415
pmid: 29393381
|
105 |
S Zhang, P Li, Z Yuan, J Tan. Platelet-rich plasma improves therapeutic effects of menstrual blood-derived stromal cells in rat model of intrauterine adhesion. Stem Cell Res Ther 2019; 10(1): 61
https://doi.org/10.1186/s13287-019-1155-7
pmid: 30770774
|
106 |
Z Yan, F Guo, Q Yuan, Y Shao, Y Zhang, H Wang, S Hao, X Du. Endometrial mesenchymal stem cells isolated from menstrual blood repaired epirubicin-induced damage to human ovarian granulosa cells by inhibiting the expression of Gadd45b in cell cycle pathway. Stem Cell Res Ther 2019; 10(1): 4
https://doi.org/10.1186/s13287-018-1101-0
pmid: 30606243
|
107 |
J Tan, P Li, Q Wang, Y Li, X Li, D Zhao, X Xu, L Kong. Autologous menstrual blood-derived stromal cells transplantation for severe Asherman’s syndrome. Hum Reprod 2016; 31(12): 2723–2729
https://doi.org/10.1093/humrep/dew235
pmid: 27664218
|
108 |
M Owen, AJ Friedenstein. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988; 136: 42–60
https://doi.org/10.1002/9780470513637.ch4
pmid: 3068016
|
109 |
L Gao, Z Huang, H Lin, Y Tian, P Li, S Lin. Bone marrow mesenchymal stem cells (BMSCs) restore functional endometrium in the rat model for severe Asherman syndrome. Reprod Sci 2019; 26(3): 436–444
https://doi.org/10.1177/1933719118799201
pmid: 30458678
|
110 |
HE Besikcioglu, GS Sarıbas, C Ozogul, M Tiryaki, S Kilic, FA Pınarlı, O Gulbahar. Determination of the effects of bone marrow derived mesenchymal stem cells and ovarian stromal stem cells on follicular maturation in cyclophosphamide induced ovarian failure in rats. Taiwan J Obstet Gynecol 2019; 58(1): 53–59
https://doi.org/10.1016/j.tjog.2018.11.010
pmid: 30638481
|
111 |
PV Guillot, C Gotherstrom, J Chan, H Kurata, NM Fisk. Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC. Stem Cells 2007; 25(3): 646–654
https://doi.org/10.1634/stemcells.2006-0208
pmid: 17124009
|
112 |
J Wang, B Ju, C Pan, Y Gu, Y Zhang, L Sun, B Zhang, Y Zhang. Application of bone marrow-derived mesenchymal stem cells in the treatment of intrauterine adhesions in rats. Cell Physiol Biochem 2016; 39(4): 1553–1560
https://doi.org/10.1159/000447857
pmid: 27614987
|
113 |
X Santamaria, S Cabanillas, I Cervelló, C Arbona, F Raga, J Ferro, J Palmero, J Remohí, A Pellicer, C Simón. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod 2016; 31(5): 1087–1096
https://doi.org/10.1093/humrep/dew042
pmid: 27005892
|
114 |
M Cocuzza, C Alvarenga, R Pagani. The epidemiology and etiology of azoospermia. Clinics (São Paulo) 2013; 68(Suppl 1): 15–26
https://doi.org/10.6061/clinics/2013(Sup01)03
pmid: 23503951
|
115 |
SC Vij, E Jr Sabanegh, A Agarwal. Biological therapy for non-obstructive azoospermia. Expert Opin Biol Ther 2018; 18(1): 19–23
https://doi.org/10.1080/14712598.2018.1380622
pmid: 28927307
|
116 |
M Kanatsu-Shinohara, T Shinohara. Spermatogonial stem cell self-renewal and development. Annu Rev Cell Dev Biol 2013; 29(1): 163–187
https://doi.org/10.1146/annurev-cellbio-101512-122353
pmid: 24099084
|
117 |
RL Brinster, JW Zimmermann. Spermatogenesis following male germ-cell transplantation. Proc Natl Acad Sci USA 1994; 91(24): 11298–11302
https://doi.org/10.1073/pnas.91.24.11298
pmid: 7972053
|
118 |
K Nayernia, J Nolte, HW Michelmann, JH Lee, K Rathsack, N Drusenheimer, A Dev, G Wulf, IE Ehrmann, DJ Elliott, V Okpanyi, U Zechner, T Haaf, A Meinhardt, W Engel. In vitro-differentiated embryonic stem cells give rise to male gametes that can generate offspring mice. Dev Cell 2006; 11(1): 125–132
https://doi.org/10.1016/j.devcel.2006.05.010
pmid: 16824959
|
119 |
K Hayashi, H Ohta, K Kurimoto, S Aramaki, M Saitou. Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells. Cell 2011; 146(4): 519–532
https://doi.org/10.1016/j.cell.2011.06.052
pmid: 21820164
|
120 |
RS Legro, SA Arslanian, DA Ehrmann, KM Hoeger, MH Murad, R Pasquali, CK; Endocrine Society Welt. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2013; 98(12): 4565–4592
https://doi.org/10.1210/jc.2013-2350
pmid: 24151290
|
121 |
R Chugh, D Ashour, N Garcia, H Park, H Takala, N Ismail, J McAllister, A Al-Hendy, A El Andaloussi. Towards cell therapy of polycystic ovary syndrome (PCOS): human mesenchymal stem cells secretome inhibits androgen production by pcos theca cells. Cytotherapy 2019; 21(5): S81
https://doi.org/10.1016/j.jcyt.2019.03.493
|
122 |
M Yin, X Wang, G Yao, M Lü, M Liang, Y Sun, F Sun. Transactivation of micrornA-320 by microRNA-383 regulates granulosa cell functions by targeting E2F1 and SF-1 proteins. J Biol Chem 2014; 289(26): 18239–18257
https://doi.org/10.1074/jbc.M113.546044
pmid: 24828505
|
123 |
BS Verkauf. Incidence, symptoms, and signs of endometriosis in fertile and infertile women. J Fla Med Assoc 1987; 74(9): 671–675
pmid: 2961844
|
124 |
Committee of the American Society for Reproductive Medicine Practice. Endometriosis and infertility: a committee opinion. Fertil Steril 2012; 98(3): 591–598
https://doi.org/10.1016/j.fertnstert.2012.05.031
pmid: 22704630
|
125 |
ML Macer, HS Taylor. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am 2012; 39(4): 535–549
https://doi.org/10.1016/j.ogc.2012.10.002
pmid: 23182559
|
126 |
Y Liu, SP Kodithuwakku, PY Ng, J Chai, EH Ng, WS Yeung, PC Ho, KF Lee. Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: an in vitro co-culture study. Hum Reprod 2010; 25(2): 479–490
https://doi.org/10.1093/humrep/dep429
pmid: 19955106
|
127 |
HN Sallam, JA Garcia-Velasco, S Dias, A Arici. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 2006; 2006(1): CD004635
https://doi.org/10.1002/14651858.CD004635.pub2
pmid: 16437491
|
128 |
L Benschop, C Farquhar, N van der Poel, MJ Heineman. Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database Syst Rev 2010; (11): CD008571
https://doi.org/10.1002/14651858.CD008571.pub2
pmid: 21069706
|
129 |
Society for Human Reproduction European, (ESHRE) Guideline Group on POI Embryology, L Webber, M Davies, R Anderson, J Bartlett, D Braat, B Cartwright, R Cifkova, Muinck Keizer-Schrama S de, E Hogervorst, F Janse, L Liao, V Vlaisavljevic, C Zillikens, N Vermeulen. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016; 31(5): 926–937
https://doi.org/10.1093/humrep/dew027
pmid: 27008889
|
130 |
K Kawamura, Y Cheng, N Suzuki, M Deguchi, Y Sato, S Takae, CH Ho, N Kawamura, M Tamura, S Hashimoto, Y Sugishita, Y Morimoto, Y Hosoi, N Yoshioka, B Ishizuka, AJ Hsueh. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA 2013; 110(43): 17474–17479
https://doi.org/10.1073/pnas.1312830110
pmid: 24082083
|
131 |
JG Asherman. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp 1950; 57(6): 892–896
https://doi.org/10.1111/j.1471-0528.1950.tb06053.x
pmid: 14804168
|
132 |
JG Schenker, EJ Margalioth. Intrauterine adhesions: an updated appraisal. Fertil Steril 1982; 37(5): 593–610
https://doi.org/10.1016/S0015-0282(16)46268-0
pmid: 6281085
|
133 |
RF Valle, JJ Sciarra. Intrauterine adhesions: hysteroscopic diagnosis, classification, treatment, and reproductive outcome. Am J Obstet Gynecol 1988; 158(6): 1459–1470
https://doi.org/10.1016/0002-9378(88)90382-1
pmid: 3381869
|
134 |
O Sugimoto. Diagnostic and therapeutic hysteroscopy for traumatic intrauterine adhesions. Am J Obstet Gynecol 1978; 131(5): 539–547
https://doi.org/10.1016/0002-9378(78)90116-3
pmid: 677196
|
135 |
KA Zikopoulos, EM Kolibianakis, P Platteau, L de Munck, H Tournaye, P Devroey, M Camus. Live delivery rates in subfertile women with Asherman’s syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reprod Biomed Online 2004; 8(6): 720–725
https://doi.org/10.1016/S1472-6483(10)61654-9
pmid: 15169591
|
136 |
F Alawadhi, H Du, H Cakmak, HS Taylor. Bone marrow-derived stem cell (BMDSC) transplantation improves fertility in a murine model of Asherman’s syndrome. PLoS One 2014; 9(5): e96662
https://doi.org/10.1371/journal.pone.0096662
pmid: 24819371
|
137 |
L Gan, H Duan, Q Xu, YQ Tang, JJ Li, FQ Sun, S Wang. Human amniotic mesenchymal stromal cell transplantation improves endometrial regeneration in rodent models of intrauterine adhesions. Cytotherapy 2017; 19(5): 603–616
https://doi.org/10.1016/j.jcyt.2017.02.003
pmid: 28285950
|
138 |
N Singh, S Mohanty, T Seth, M Shankar, S Bhaskaran, S Dharmendra. Autologous stem cell transplantation in refractory Asherman’s syndrome: a novel cell based therapy. J Hum Reprod Sci 2014; 7(2): 93–98
https://doi.org/10.4103/0974-1208.138864
pmid: 25191021
|
139 |
FJ Vizoso, N Eiro, S Cid, J Schneider, R Perez-Fernandez. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci 2017; 18(9): 1852
https://doi.org/10.3390/ijms18091852
pmid: 28841158
|
140 |
DC Ding, WC Shyu, SZ Lin. Mesenchymal stem cells. Cell Transplant 2011; 20(1): 5–14
https://doi.org/10.3727/096368910X
pmid: 21396235
|
141 |
I Ullah, RB Subbarao, GJ Rho. Human mesenchymal stem cells—current trends and future prospective. Biosci Rep 2015; 35(2): e00191
https://doi.org/10.1042/BSR20150025
pmid: 25797907
|
142 |
JB Sneddon, Q Tang, P Stock, JA Bluestone, S Roy, T Desai, M Hebrok. Stem cell therapies for treating diabetes: progress and remaining challenges. Cell Stem Cell 2018; 22(6): 810–823
https://doi.org/10.1016/j.stem.2018.05.016
pmid: 29859172
|
143 |
H Du, HS Taylor. Stem cells and female reproduction. Reprod Sci 2009; 16(2): 126–139
https://doi.org/10.1177/1933719108329956
pmid: 19208782
|
144 |
F Liu, S Hu, H Yang, Z Li, K Huang, T Su, S Wang, K Cheng. Hyaluronic acid hydrogel integrated with mesenchymal stem cell-secretome to treat endometrial injury in a rat model of Asherman’s syndrome. Adv Healthc Mater 2019; 8(14): e1900411
https://doi.org/10.1002/adhm.201900411
pmid: 31148407
|
145 |
M Mendt, K Rezvani, E Shpall. Mesenchymal stem cell-derived exosomes for clinical use. Bone Marrow Transplant 2019; 54(Suppl 2): 789–792
https://doi.org/10.1038/s41409-019-0616-z
pmid: 31431712
|
146 |
M Ullah, Y Qiao, W Concepcion, AS Thakor. Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges. Stem Cell Res Ther 2019; 10(1): 347
https://doi.org/10.1186/s13287-019-1468-6
pmid: 31771657
|
147 |
C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, R Andriantsitohaina, A Antoniou, T Arab, F Archer, GK Atkin-Smith, DC Ayre, JM Bach, D Bachurski, H Baharvand, L Balaj, S Baldacchino, NN Bauer, AA Baxter, M Bebawy, C Beckham, A Bedina Zavec, A Benmoussa, AC Berardi, P Bergese, E Bielska, C Blenkiron, S Bobis-Wozowicz, E Boilard, W Boireau, A Bongiovanni, FE Borràs, S Bosch, CM Boulanger, X Breakefield, AM Breglio, MÁ Brennan, DR Brigstock, A Brisson, ML Broekman, JF Bromberg, P Bryl-Górecka, S Buch, AH Buck, D Burger, S Busatto, D Buschmann, B Bussolati, EI Buzás, JB Byrd, G Camussi, DR Carter, S Caruso, LW Chamley, YT Chang, C Chen, S Chen, L Cheng, AR Chin, A Clayton, SP Clerici, A Cocks, E Cocucci, RJ Coffey, A Cordeiro-da-Silva, Y Couch, FA Coumans, B Coyle, R Crescitelli, MF Criado, C D’Souza-Schorey, S Das, A Datta Chaudhuri, P de Candia, EF De Santana, O De Wever, HA Del Portillo, T Demaret, S Deville, A Devitt, B Dhondt, D Di Vizio, LC Dieterich, V Dolo, AP Dominguez Rubio, M Dominici, MR Dourado, TA Driedonks, FV Duarte, HM Duncan, RM Eichenberger, K Ekström, S El Andaloussi, C Elie-Caille, U Erdbrügger, JM Falcón-Pérez, F Fatima, JE Fish, M Flores-Bellver, A Försönits, A Frelet-Barrand, F Fricke, G Fuhrmann, S Gabrielsson, A Gámez-Valero, C Gardiner, K Gärtner, R Gaudin, YS Gho, B Giebel, C Gilbert, M Gimona, I Giusti, DC Goberdhan, A Görgens, SM Gorski, DW Greening, JC Gross, A Gualerzi, GN Gupta, D Gustafson, A Handberg, RA Haraszti, P Harrison, H Hegyesi, A Hendrix, AF Hill, FH Hochberg, KF Hoffmann, B Holder, H Holthofer, B Hosseinkhani, G Hu, Y Huang, V Huber, S Hunt, AG Ibrahim, T Ikezu, JM Inal, M Isin, A Ivanova, HK Jackson, S Jacobsen, SM Jay, M Jayachandran, G Jenster, L Jiang, SM Johnson, JC Jones, A Jong, T Jovanovic-Talisman, S Jung, R Kalluri, SI Kano, S Kaur, Y Kawamura, ET Keller, D Khamari, E Khomyakova, A Khvorova, P Kierulf, KP Kim, T Kislinger, M Klingeborn, 2nd Klinke DJ, M Kornek, MM Kosanović,ÁF Kovács, EM Krämer-Albers, S Krasemann, M Krause, IV Kurochkin, GD Kusuma, S Kuypers, S Laitinen, SM Langevin, LR Languino, J Lannigan, C Lässer, LC Laurent, G Lavieu, E Lázaro-Ibáñez, S Le Lay, MS Lee, YXF Lee, DS Lemos, M Lenassi, A Leszczynska, IT Li, K Liao, SF Libregts, E Ligeti, R Lim, SK Lim, A Linē, K Linnemannstöns, A Llorente, CA Lombard, MJ Lorenowicz,ÁM Lörincz, J Lötvall, J Lovett, MC Lowry, X Loyer, Q Lu, B Lukomska, TR Lunavat, SL Maas, H Malhi, A Marcilla, J Mariani, J Mariscal, ES Martens-Uzunova, L Martin-Jaular, MC Martinez, VR Martins, M Mathieu, S Mathivanan, M Maugeri, LK McGinnis, MJ McVey, Jr Meckes DG, KL Meehan, I Mertens, VR Minciacchi, A Möller, M Møller Jørgensen, A Morales-Kastresana, J Morhayim, F Mullier, M Muraca, L Musante, V Mussack, DC Muth, KH Myburgh, T Najrana, M Nawaz, I Nazarenko, P Nejsum, C Neri, T Neri, R Nieuwland, L Nimrichter, JP Nolan, EN Nolte-’t Hoen, N Noren Hooten, L O’Driscoll, T O’Grady, A O’Loghlen, T Ochiya, M Olivier, A Ortiz, LA Ortiz, X Osteikoetxea, O Østergaard, M Ostrowski, J Park, DM Pegtel, H Peinado, F Perut, MW Pfaffl, DG Phinney, BC Pieters, RC Pink, DS Pisetsky, E Pogge von Strandmann, I Polakovicova, IK Poon, BH Powell, I Prada, L Pulliam, P Quesenberry, A Radeghieri, RL Raffai, S Raimondo, J Rak, MI Ramirez, G Raposo, MS Rayyan, N Regev-Rudzki, FL Ricklefs, PD Robbins, DD Roberts, SC Rodrigues, E Rohde, S Rome, KM Rouschop, A Rughetti, AE Russell, P Saá, S Sahoo, E Salas-Huenuleo, C Sánchez, JA Saugstad, MJ Saul, RM Schiffelers, R Schneider, TH Schøyen, A Scott, E Shahaj, S Sharma, O Shatnyeva, F Shekari, GV Shelke, AK Shetty, K Shiba, PR Siljander, AM Silva, A Skowronek, 2nd Snyder OL, RP Soares, BW Sódar, C Soekmadji, J Sotillo, PD Stahl, W Stoorvogel, SL Stott, EF Strasser, S Swift, H Tahara, M Tewari, K Timms, S Tiwari, R Tixeira, M Tkach, WS Toh, R Tomasini, AC Torrecilhas, JP Tosar, V Toxavidis, L Urbanelli, P Vader, BW van Balkom, SG van der Grein, J Van Deun, MJ van Herwijnen, K Van Keuren-Jensen, G van Niel, ME van Royen, AJ van Wijnen, MH Vasconcelos, Jr Vechetti IJ, TD Veit, LJ Vella,É Velot, FJ Verweij, B Vestad, JL Viñas, T Visnovitz, KV Vukman, J Wahlgren, DC Watson, MH Wauben, A Weaver, JP Webber, V Weber, AM Wehman, DJ Weiss, JA Welsh, S Wendt, AM Wheelock, Z Wiener, L Witte, J Wolfram, A Xagorari, P Xander, J Xu, X Yan, M Yáñez-Mó, H Yin, Y Yuana, V Zappulli, J Zarubova, V Žėkas, JY Zhang, Z Zhao, L Zheng, AR Zheutlin, AM Zickler, P Zimmermann, AM Zivkovic, D Zocco, EK Zuba-Surma. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018; 7(1): 1535750
https://doi.org/10.1080/20013078.2018.1535750
pmid: 30637094
|
148 |
AG Zhao, K Shah, B Cromer, H Sumer. Mesenchymal stem cell-derived extracellular vesicles and their therapeutic potential. Stem Cells Int 2020; 2020: 8825771
https://doi.org/10.1155/2020/8825771
pmid: 32908543
|
149 |
Y Yu, X Lin, Q Wang, M He, Y Chau. Long-term therapeutic effect in nonhuman primate eye from a single injection of anti-VEGF controlled release hydrogel. Bioeng Transl Med 2019; 4(2): e10128
https://doi.org/10.1002/btm2.10128
pmid: 31249878
|
150 |
S Kourembanas. Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol 2015; 77(1): 13–27
https://doi.org/10.1146/annurev-physiol-021014-071641
pmid: 25293529
|
151 |
G Qiu, G Zheng, M Ge, J Wang, R Huang, Q Shu, J Xu. Functional proteins of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther 2019; 10(1): 359
https://doi.org/10.1186/s13287-019-1484-6
pmid: 31779700
|
152 |
G Raposo, W Stoorvogel. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200(4): 373–383
https://doi.org/10.1083/jcb.201211138
pmid: 23420871
|
153 |
HS Joo, JH Suh, HJ Lee, ES Bang, JM Lee. Current knowledge and future perspectives on mesenchymal stem cell-derived exosomes as a new therapeutic agent. Int J Mol Sci 2020; 21(3): 727
https://doi.org/10.3390/ijms21030727
pmid: 31979113
|
154 |
H Abbaszadeh, F Ghorbani, M Derakhshani, A Movassaghpour, M Yousefi. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles: a novel therapeutic paradigm. J Cell Physiol 2020; 235(2): 706–717
https://doi.org/10.1002/jcp.29004
pmid: 31254289
|
155 |
DG Phinney, M Di Giuseppe, J Njah, E Sala, S Shiva, CM St Croix, DB Stolz, SC Watkins, YP Di, GD Leikauf, J Kolls, DW Riches, G Deiuliis, N Kaminski, SV Boregowda, DH McKenna, LA Ortiz. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun 2015; 6(1): 8472
https://doi.org/10.1038/ncomms9472
pmid: 26442449
|
156 |
N Domniz, D Meirow. Premature ovarian insufficiency and autoimmune diseases. Best Pract Res Clin Obstet Gynaecol 2019; 60: 42–55
https://doi.org/10.1016/j.bpobgyn.2019.07.008
pmid: 31495598
|
157 |
M De Vos, P Devroey, BC Fauser. Primary ovarian insufficiency. Lancet 2010; 376(9744): 911–921
https://doi.org/10.1016/S0140-6736(10)60355-8
pmid: 20708256
|
158 |
B Huang, C Qian, C Ding, Q Meng, Q Zou, H Li. Fetal liver mesenchymal stem cells restore ovarian function in premature ovarian insufficiency by targeting MT1. Stem Cell Res Ther 2019; 10(1): 362
https://doi.org/10.1186/s13287-019-1490-8
pmid: 31783916
|
159 |
EH Kim, BH Jeon, J Kim, YM Kim, Y Han, K Ahn, HK Cheong. Exposure to phthalates and bisphenol A are associated with atopic dermatitis symptoms in children: a time-series analysis. Environ Health 2017; 16(1): 24
https://doi.org/10.1186/s12940-017-0225-5
pmid: 28274229
|
160 |
EA Ford, EL Beckett, SD Roman, EA McLaughlin, JM Sutherland. Advances in human primordial follicle activation and premature ovarian insufficiency. Reproduction 2020; 159(1): R15–R29
https://doi.org/10.1530/REP-19-0201
pmid: 31376814
|
161 |
I Huhtaniemi, O Hovatta, A La Marca, G Livera, D Monniaux, L Persani, A Heddar, K Jarzabek, T Laisk-Podar, A Salumets, JS Tapanainen, RA Veitia, JA Visser, P Wieacker, S Wolczynski, M Misrahi. Advances in the molecular pathophysiology, genetics, and treatment of primary ovarian insufficiency. Trends Endocrinol Metab 2018; 29(6): 400–419
https://doi.org/10.1016/j.tem.2018.03.010
pmid: 29706485
|
162 |
V Wesevich, AN Kellen, L Pal. Recent advances in understanding primary ovarian insufficiency. F1000 Res 2020; 9: F1000 Faculty Rev-1101
https://doi.org/10.12688/f1000research.26423.1
pmid: 32934798
|
163 |
S Caburet, VA Arboleda, E Llano, PA Overbeek, JL Barbero, K Oka, W Harrison, D Vaiman, Z Ben-Neriah, I García-Tuñón, M Fellous, AM Pendás, RA Veitia, E Vilain. Mutant cohesin in premature ovarian failure. N Engl J Med 2014; 370(10): 943–949
https://doi.org/10.1056/NEJMoa1309635
pmid: 24597867
|
164 |
J Bouilly, I Beau, S Barraud, V Bernard, K Azibi, J Fagart, A Fèvre, AL Todeschini, RA Veitia, C Beldjord, B Delemer, C Dodé, J Young, N Binart. Identification of multiple gene mutations accounts for a new genetic architecture of primary ovarian insufficiency. J Clin Endocrinol Metab 2016; 101(12): 4541–4550
https://doi.org/10.1210/jc.2016-2152
pmid: 27603904
|
165 |
S Jaillard, K Bell, L Akloul, K Walton, K McElreavy, WA Stocker, M Beaumont, C Harrisson, T Jääskeläinen, JJ Palvimo, G Robevska, E Launay, AP Satié, N Listyasari, C Bendavid, R Sreenivasan, S Duros, den Bergen J van, C Henry, M Domin-Bernhard, L Cornevin, N Dejucq-Rainsford, MA Belaud-Rotureau, S Odent, KL Ayers, C Ravel, EJ Tucker, AH Sinclair. New insights into the genetic basis of premature ovarian insufficiency: novel causative variants and candidate genes revealed by genomic sequencing. Maturitas 2020; 141: 9–19
https://doi.org/10.1016/j.maturitas.2020.06.004
pmid: 33036707
|
166 |
T Liu, Y Liu, Y Huang, J Chen, Z Yu, C Chen, L Lai. miR-15b induces premature ovarian failure in mice via inhibition of α-Klotho expression in ovarian granulosa cells. Free Radic Biol Med 2019; 141: 383–392
https://doi.org/10.1016/j.freeradbiomed.2019.07.010
pmid: 31310795
|
167 |
L Persani, R Rossetti, C Cacciatore, S Fabre. Genetic defects of ovarian TGF-β-like factors and premature ovarian failure. J Endocrinol Invest 2011; 34(3): 244–251
https://doi.org/10.1007/BF03347073
pmid: 21297384
|
168 |
J Grosbois, I Demeestere. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation. Hum Reprod 2018; 33(9): 1705–1714
https://doi.org/10.1093/humrep/dey250
pmid: 30032281
|
169 |
S Dragojević-Dikić, D Marisavljević, A Mitrović, S Dikić, T Jovanović, S Janković-Raznatović. An immunological insight into premature ovarian failure (POF). Autoimmun Rev 2010; 9(11): 771–774
https://doi.org/10.1016/j.autrev.2010.06.008
pmid: 20601203
|
170 |
CB Coulam, JJ Stern. Immunology of ovarian failure. Am J Reprod Immunol 1991; 25(4): 169–174
https://doi.org/10.1111/j.1600-0897.1991.tb01089.x
pmid: 1786086
|
171 |
M Shen, Y Jiang, Z Guan, Y Cao, L Li, H Liu, SC Sun. Protective mechanism of FSH against oxidative damage in mouse ovarian granulosa cells by repressing autophagy. Autophagy 2017; 13(8): 1364–1385
https://doi.org/10.1080/15548627.2017.1327941
pmid: 28598230
|
172 |
B Huang, J Lu, C Ding, Q Zou, W Wang, H Li. Exosomes derived from human adipose mesenchymal stem cells improve ovary function of premature ovarian insufficiency by targeting SMAD. Stem Cell Res Ther 2018; 9(1): 216
https://doi.org/10.1186/s13287-018-0953-7
pmid: 30092819
|
173 |
J Zhang, H Yin, H Jiang, X Du, Z Yang. The protective effects of human umbilical cord mesenchymal stem cell-derived extracellular vesicles on cisplatin-damaged granulosa cells. Taiwan J Obstet Gynecol 2020; 59(4): 527–533
https://doi.org/10.1016/j.tjog.2020.05.010
pmid: 32653124
|
174 |
Z Yang, X Du, C Wang, J Zhang, C Liu, Y Li, H Jiang. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice. Stem Cell Res Ther 2019; 10(1): 250
https://doi.org/10.1186/s13287-019-1327-5
pmid: 31412919
|
175 |
S Zhang, B Huang, P Su, Q Chang, P Li, A Song, X Zhao, Z Yuan, J Tan. Concentrated exosomes from menstrual blood-derived stromal cells improves ovarian activity in a rat model of premature ovarian insufficiency. Stem Cell Res Ther 2021; 12(1): 178
https://doi.org/10.1186/s13287-021-02255-3
pmid: 33712079
|
176 |
GY Xiao, CC Cheng, YS Chiang, WT Cheng, IH Liu, SC Wu. Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy. Sci Rep 2016; 6(1): 23120
https://doi.org/10.1038/srep23120
pmid: 26979400
|
177 |
L Sun, D Li, K Song, J Wei, S Yao, Z Li, X Su, X Ju, L Chao, X Deng, B Kong, L Li. Exosomes derived from human umbilical cord mesenchymal stem cells protect against cisplatin-induced ovarian granulosa cell stress and apoptosis in vitro. Sci Rep 2017; 7(1): 2552
https://doi.org/10.1038/s41598-017-02786-x
pmid: 28566720
|
178 |
W Boecker, Horn L van, G Stenman, C Stürken, U Schumacher, T Loening, L Liesenfeld, E Korsching, D Gläser, K Tiemann, I Buchwalow. Spatially correlated phenotyping reveals K5-positive luminal progenitor cells and p63-K5/14-positive stem cell-like cells in human breast epithelium. Lab Invest 2018; 98(8): 1065–1075
https://doi.org/10.1038/s41374-018-0054-3
pmid: 29743728
|
179 |
E Thabet, A Yusuf, DA Abdelmonsif, I Nabil, G Mourad, RA Mehanna. Extracellular vesicles miRNA-21: a potential therapeutic tool in premature ovarian dysfunction. Mol Hum Reprod 2020; 26(12): 906–919
https://doi.org/10.1093/molehr/gaaa068
pmid: 33049041
|
180 |
B Sun, Y Ma, F Wang, L Hu, Y Sun. miR-644-5p carried by bone mesenchymal stem cell-derived exosomes targets regulation of p53 to inhibit ovarian granulosa cell apoptosis. Stem Cell Res Ther 2019; 10(1): 360
https://doi.org/10.1186/s13287-019-1442-3
pmid: 31783913
|
181 |
C Ding, C Qian, S Hou, J Lu, Q Zou, H Li, B Huang. Exosomal miRNA-320a is released from hAMSCs and regulates SIRT4 to prevent reactive oxygen species generation in POI. Mol Ther Nucleic Acids 2020; 21: 37–50
https://doi.org/10.1016/j.omtn.2020.05.013
pmid: 32506013
|
182 |
C Liu, H Yin, H Jiang, X Du, C Wang, Y Liu, Y Li, Z Yang. Extracellular vesicles derived from mesenchymal stem cells recover fertility of premature ovarian insufficiency mice and the effects on their offspring. Cell Transplant 2020; 29: 963689720923575
https://doi.org/10.1177/0963689720923575
pmid: 32363925
|
183 |
RJ Norman, R Wu, MT Stankiewicz. 4: Polycystic ovary syndrome. Med J Aust 2004; 180(3): 132–137
https://doi.org/10.5694/j.1326-5377.2004.tb05838.x
pmid: 14748678
|
184 |
R Blázquez, FM Sánchez-Margallo, V Álvarez, E Matilla, N Hernández, F Marinaro, M Gómez-Serrano, I Jorge, JG Casado, B Macías-García. Murine embryos exposed to human endometrial MSCs-derived extracellular vesicles exhibit higher VEGF/PDGF AA release, increased blastomere count and hatching rates. PLoS One 2018; 13(4): e0196080
https://doi.org/10.1371/journal.pone.0196080
pmid: 29684038
|
185 |
F Marinaro, B Macías-García, FM Sánchez-Margallo, R Blázquez, V Álvarez, E Matilla, N Hernández, M Gómez-Serrano, I Jorge, J Vázquez, L González-Fernández, E Pericuesta, A Gutiérrez-Adán, JG Casado. Extracellular vesicles derived from endometrial human mesenchymal stem cells enhance embryo yield and quality in an aged murine model. Biol Reprod 2019; 100(5): 1180–1192
https://doi.org/10.1093/biolre/ioy263
pmid: 30596891
|
186 |
Lancet Diabetes Endocrinology The. Empowering women with PCOS. Lancet Diabetes Endocrinol 2019; 7(10): 737
https://doi.org/10.1016/S2213-8587(19)30289-X
pmid: 31501041
|
187 |
HF Escobar-Morreale. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol 2018; 14(5): 270–284
https://doi.org/10.1038/nrendo.2018.24
pmid: 29569621
|
188 |
X Liang, L Zhang, S Wang, Q Han, RC Zhao. Exosomes secreted by mesenchymal stem cells promote endothelial cell angiogenesis by transferring miR-125a. J Cell Sci 2016; 129(11): 2182–2189
https://doi.org/10.1242/jcs.170373
pmid: 27252357
|
189 |
AH Balen, LC Morley, M Misso, S Franks, RS Legro, CN Wijeyaratne, E Stener-Victorin, BC Fauser, RJ Norman, H Teede. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 2016; 22(6): 687–708
https://doi.org/10.1093/humupd/dmw025
pmid: 27511809
|
190 |
A Madkour, N Bouamoud, I Kaarouch, N Louanjli, B Saadani, S Assou, S Aboulmaouahib, O Sefrioui, S Amzazi, H Copin, M Benkhalifa. Follicular fluid and supernatant from cultured cumulus-granulosa cells improve in vitro maturation in patients with polycystic ovarian syndrome. Fertil Steril 2018; 110(4): 710–719
https://doi.org/10.1016/j.fertnstert.2018.04.038
pmid: 30196968
|
191 |
Y Zhao, M Tao, M Wei, S Du, H Wang, X Wang. Mesenchymal stem cells derived exosomal miR-323-3p promotes proliferation and inhibits apoptosis of cumulus cells in polycystic ovary syndrome (PCOS). Artif Cells Nanomed Biotechnol 2019; 47(1): 3804–3813
https://doi.org/10.1080/21691401.2019.1669619
pmid: 31549864
|
192 |
CA Salazar, K Isaacson, S Morris. A comprehensive review of Asherman’s syndrome: causes, symptoms and treatment options. Curr Opin Obstet Gynecol 2017; 29(4): 249–256
https://doi.org/10.1097/GCO.0000000000000378
pmid: 28582327
|
193 |
CM March. Asherman’s syndrome. Semin Reprod Med 2011; 29(2): 83–94
https://doi.org/10.1055/s-0031-1272470
pmid: 21437822
|
194 |
ST Lo, P Ramsay, R Pierson, F Manconi, MG Munro, IS Fraser. Endometrial thickness measured by ultrasound scan in women with uterine outlet obstruction due to intrauterine or upper cervical adhesions. Hum Reprod 2008; 23(2): 306–309
https://doi.org/10.1093/humrep/dem393
pmid: 18083747
|
195 |
S Xiao, Y Wan, M Xue, X Zeng, F Xiao, D Xu, X Yang, P Zhang, W Sheng, J Xu, S Zhou. Etiology, treatment, and reproductive prognosis of women with moderate-to-severe intrauterine adhesions. Int J Gynaecol Obstet 2014; 125(2): 121–124
https://doi.org/10.1016/j.ijgo.2013.10.026
pmid: 24598346
|
196 |
X Bai, J Liu, S Cao, L Wang. Mechanisms of endometrial fibrosis and the potential application of stem cell therapy. Discov Med 2019; 27(150): 267–279
pmid: 31421695
|
197 |
X Santamaria, K Isaacson, C Simón. Asherman’s syndrome: it may not be all our fault. Hum Reprod 2018; 33(8): 1374–1380
https://doi.org/10.1093/humrep/dey232
pmid: 31986212
|
198 |
U Salma, M Xue, MS Ali Sheikh, X Guan, B Xu, A Zhang, L Huang, D Xu. Role of transforming growth factor-β1 and Smads signaling pathway in intrauterine adhesion. Mediators Inflamm 2016; 2016: 4158287
https://doi.org/10.1155/2016/4158287
pmid: 26997760
|
199 |
X Wang, N Ma, Q Sun, C Huang, Y Liu, X Luo. Elevated NF-κB signaling in Asherman syndrome patients and animal models. Oncotarget 2017; 8(9): 15399–15406
https://doi.org/10.18632/oncotarget.14853
pmid: 28148903
|
200 |
X Xue, Q Chen, G Zhao, JY Zhao, Z Duan, PS Zheng. The overexpression of TGF-β and CCN2 in intrauterine adhesions involves the NF-κB signaling pathway. PLoS One 2015; 10(12): e0146159
https://doi.org/10.1371/journal.pone.0146159
pmid: 26719893
|
201 |
HY Zhu, TX Ge, YB Pan, SY Zhang. Advanced role of hippo signaling in endometrial fibrosis: implications for intrauterine adhesion. Chin Med J (Engl) 2017; 130(22): 2732–2737
https://doi.org/10.4103/0366-6999.218013
pmid: 29133764
|
202 |
A Akhmetshina, K Palumbo, C Dees, C Bergmann, P Venalis, P Zerr, A Horn, T Kireva, C Beyer, J Zwerina, H Schneider, A Sadowski, MO Riener, OA MacDougald, O Distler, G Schett, JH Distler. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun 2012; 3(1): 735
https://doi.org/10.1038/ncomms1734
pmid: 22415826
|
203 |
L Liu, G Chen, T Chen, W Shi, H Hu, K Song, R Huang, H Cai, Y He. si-SNHG5-FOXF2 inhibits TGF-β1-induced fibrosis in human primary endometrial stromal cells by the Wnt/β-catenin signalling pathway. Stem Cell Res Ther 2020; 11(1): 1–17
https://doi.org/10.1186/s13287-020-01990-3
pmid: 31900237
|
204 |
G Chen, L Liu, J Sun, L Zeng, H Cai, Y He. Foxf2 and Smad6 co-regulation of collagen 5A2 transcription is involved in the pathogenesis of intrauterine adhesion. J Cell Mol Med 2020; 24(5): 2802–2818
https://doi.org/10.1111/jcmm.14708
pmid: 32022446
|
205 |
RKK Leung, Y Lin, Y Liu. Recent advances in understandings towards pathogenesis and treatment for intrauterine adhesion and disruptive insights from single-cell analysis. Reprod Sci 2021; 28(7): 1812–1826
https://doi.org/10.1007/s43032-020-00343-y
pmid: 33125685
|
206 |
M Liu, D Zhao, X Wu, S Guo, L Yan, S Zhao, H Li, Y Wang, F Rong. miR-466 and NUS1 regulate the AKT/nuclear factor kappa B (NFκB) signaling pathway in intrauterine adhesions in a rat model. Med Sci Monit 2019; 25: 4094–4103
https://doi.org/10.12659/MSM.914202
pmid: 31154456
|
207 |
Q Xu, H Duan, L Gan, X Liu, F Chen, X Shen, YQ Tang, S Wang. MicroRNA-1291 promotes endometrial fibrosis by regulating the ArhGAP29-RhoA/ROCK1 signaling pathway in a murine model. Mol Med Rep 2017; 16(4): 4501–4510
https://doi.org/10.3892/mmr.2017.7210
pmid: 28849001
|
208 |
H Zhu, Y Pan, Y Jiang, J Li, Y Zhang, S Zhang. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor β signaling in human endometrial stromal cells. Hum Reprod 2019; 34(4): 635–645
https://doi.org/10.1093/humrep/dez001
pmid: 30715393
|
209 |
S Zhao, W Qi, J Zheng, Y Tian, X Qi, D Kong, J Zhang, X Huang. Exosomes derived from adipose mesenchymal stem cells restore functional endometrium in a rat model of intrauterine adhesions. Reprod Sci 2020; 27(6): 1266–1275
https://doi.org/10.1007/s43032-019-00112-6
pmid: 31933162
|
210 |
L Xin, X Lin, F Zhou, C Li, X Wang, H Yu, Y Pan, H Fei, L Ma, S Zhang. A scaffold laden with mesenchymal stem cell-derived exosomes for promoting endometrium regeneration and fertility restoration through macrophage immunomodulation. Acta Biomater 2020; 113: 252–266
https://doi.org/10.1016/j.actbio.2020.06.029
pmid: 32574858
|
211 |
C Perrini, MG Strillacci, A Bagnato, P Esposti, MG Marini, B Corradetti, D Bizzaro, A Idda, S Ledda, E Capra, F Pizzi, A Lange-Consiglio, F Cremonesi. Microvesicles secreted from equine amniotic-derived cells and their potential role in reducing inflammation in endometrial cells in an in-vitro model. Stem Cell Res Ther 2016; 7(1): 169
https://doi.org/10.1186/s13287-016-0429-6
pmid: 27863532
|
212 |
Y Yao, R Chen, G Wang, Y Zhang, F Liu. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium. Stem Cell Res Ther 2019; 10(1): 225
https://doi.org/10.1186/s13287-019-1332-8
pmid: 31358049
|
213 |
GS Saribas, C Ozogul, M Tiryaki, F Alpaslan Pinarli, S Hamdemir Kilic. Effects of uterus derived mesenchymal stem cells and their exosomes on Asherman’s syndrome. Acta Histochem 2020; 122(1): 151465
https://doi.org/10.1016/j.acthis.2019.151465
pmid: 31776004
|
214 |
Y Chang, Y Liu, X Li. Exosomes derived from human umbilical cord mesenchymal stem cells promote proliferation of endometrial stromal cell. Fertil Steril 2020; 114(3): e530
https://doi.org/10.1016/j.fertnstert.2020.09.035
|
215 |
OS Aworunse, O Adeniji, OL Oyesola, I Isewon, J Oyelade, OO Obembe. Genomic interventions in medicine. Bioinform Biol Insights 2018; 12: 1177932218816100
https://doi.org/10.1177/1177932218816100
pmid: 30546257
|
216 |
LH Goetz, NJ Schork. Personalized medicine: motivation, challenges, and progress. Fertil Steril 2018; 109(6): 952–963
https://doi.org/10.1016/j.fertnstert.2018.05.006
pmid: 29935653
|
217 |
PY Zhang, Y Yu. Precise personalized medicine in gynecology cancer and infertility. Front Cell Dev Biol 2020; 7: 382
https://doi.org/10.3389/fcell.2019.00382
pmid: 32010694
|
218 |
A Ferlin, B Arredi, C Foresta. Genetic causes of male infertility. Reprod Toxicol 2006; 22(2): 133–141
https://doi.org/10.1016/j.reprotox.2006.04.016
pmid: 16806807
|
219 |
A Bracke, K Peeters, U Punjabi, D Hoogewijs, S Dewilde. A search for molecular mechanisms underlying male idiopathic infertility. Reprod Biomed Online 2018; 36(3): 327–339
https://doi.org/10.1016/j.rbmo.2017.12.005
pmid: 29336995
|
220 |
E Ventimiglia, F Montorsi, A Salonia. Comorbidities and male infertility: a worrisome picture. Curr Opin Urol 2016; 26(2): 146–151
https://doi.org/10.1097/MOU.0000000000000259
pmid: 26765042
|
221 |
A Jungwirth, A Giwercman, H Tournaye, T Diemer, Z Kopa, G Dohle, C; European Association of Urology Working Group on Male Infertility Krausz. European Association of Urology guidelines on Male Infertility: the 2012 update. Eur Urol 2012; 62(2): 324–332
https://doi.org/10.1016/j.eururo.2012.04.048
pmid: 22591628
|
222 |
MS Oud, L Volozonoka, RM Smits, LELM Vissers, L Ramos, JA Veltman. A systematic review and standardized clinical validity assessment of male infertility genes. Hum Reprod 2019; 34(5): 932–941
https://doi.org/10.1093/humrep/dez022
pmid: 30865283
|
223 |
C Krausz, AR Escamilla, C Chianese. Genetics of male infertility: from research to clinic. Reproduction 2015; 150(5): R159–R174
https://doi.org/10.1530/REP-15-0261
pmid: 26447148
|
224 |
F Cariati, V D’Argenio, R Tomaiuolo. The evolving role of genetic tests in reproductive medicine. J Transl Med 2019; 17(1): 267
https://doi.org/10.1186/s12967-019-2019-8
pmid: 31412890
|
225 |
C Krausz, S Degl’Innocenti. Y chromosome and male infertility: update, 2006. Front Biosci 2006; 11(1): 3049–3061
https://doi.org/10.2741/2032
pmid: 16720375
|
226 |
IW Kim, AC Khadilkar, EY Ko, ES Jr Sabanegh. 47, XYY syndrome and male infertility. Rev Urol 2013; 15(4): 188–196
pmid: 24659916
|
227 |
C Krausz, L Hoefsloot, M Simoni, F; European Academy of Andrology; European Molecular Genetics Quality Network Tüttelmann. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state-of-the-art 2013. Andrology 2014; 2(1): 5–19
https://doi.org/10.1111/j.2047-2927.2013.00173.x
pmid: 24357628
|
228 |
L Stuppia, V Gatta, G Calabrese, P Guanciali Franchi, E Morizio, C Bombieri, R Mingarelli, V Sforza, G Frajese, R Tenaglia, G Palka. A quarter of men with idiopathic oligo-azoospermia display chromosomal abnormalities and microdeletions of different types in interval 6 of Yq11. Hum Genet 1998; 102(5): 566–570
https://doi.org/10.1007/s004390050741
pmid: 9654206
|
229 |
PC Patsalis, C Sismani, L Quintana-Murci, F Taleb-Bekkouche, C Krausz, K McElreavey. Effects of transmission of Y chromosome AZFc deletions. Lancet 2002; 360(9341): 1222–1224
https://doi.org/10.1016/S0140-6736(02)11248-7
pmid: 12401251
|
230 |
P Asero, AE Calogero, RA Condorelli, L Mongioi’, E Vicari, F Lanzafame, R Crisci, Vignera S La. Relevance of genetic investigation in male infertility. J Endocrinol Invest 2014; 37(5): 415–427
https://doi.org/10.1007/s40618-014-0053-1
pmid: 24458834
|
231 |
T Kuroda-Kawaguchi, H Skaletsky, LG Brown, PJ Minx, HS Cordum, RH Waterston, RK Wilson, S Silber, R Oates, S Rozen, DC Page. The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet 2001; 29(3): 279–286
https://doi.org/10.1038/ng757
pmid: 11687796
|
232 |
A Ferlin, A Garolla, C Foresta. Chromosome abnormalities in sperm of individuals with constitutional sex chromosomal abnormalities. Cytogenet Genome Res 2005; 111(3–4): 310–316
https://doi.org/10.1159/000086905
pmid: 16192710
|
233 |
N Schultz, FK Hamra, DL Garbers. A multitude of genes expressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets. Proc Natl Acad Sci USA 2003; 100(21): 12201–12206
https://doi.org/10.1073/pnas.1635054100
pmid: 14526100
|
234 |
E Mastantuoni, G Saccone, HB Al-Kouatly, M Paternoster, P D’Alessandro, B Arduino, L Carbone, G Esposito, A Raffone, Vivo V De, GM Maruotti, V Berghella, F Zullo. Expanded carrier screening: a current perspective. Eur J Obstet Gynecol Reprod Biol 2018; 230: 41–54
https://doi.org/10.1016/j.ejogrb.2018.09.014
pmid: 30240948
|
235 |
SJ Morin, J Eccles, A Iturriaga, RS Zimmerman. Translocations, inversions and other chromosome rearrangements. Fertil Steril 2017; 107(1): 19–26
https://doi.org/10.1016/j.fertnstert.2016.10.013
pmid: 27793378
|
236 |
LJ Folsom, JS Fuqua. Reproductive issues in women with turner syndrome. Endocrinol Metab Clin North Am 2015; 44(4): 723–737
https://doi.org/10.1016/j.ecl.2015.07.004
pmid: 26568488
|
237 |
K Oktay, G Bedoschi, K Berkowitz, R Bronson, B Kashani, P McGovern, L Pal, G Quinn, K Rubin. Fertility preservation in women with Turner syndrome: a comprehensive review and practical guidelines. J Pediatr Adolesc Gynecol 2016; 29(5): 409–416
https://doi.org/10.1016/j.jpag.2015.10.011
pmid: 26485320
|
238 |
M Chen, S Wei, J Hu, S Quan. Can comprehensive chromosome screening technology improve IVF/ICSI outcomes? A meta-analysis.. PLoS One 2015; 10(10): e0140779
https://doi.org/10.1371/journal.pone.0140779
pmid: 26470028
|
239 |
L Man, J Lekovich, Z Rosenwaks, J Gerhardt. Fragile X-associated diminished ovarian reserve and primary ovarian insufficiency from molecular mechanisms to clinical manifestations. Front Mol Neurosci 2017; 10: 290
https://doi.org/10.3389/fnmol.2017.00290
pmid: 28955201
|
240 |
LR Hoyos, M Thakur. Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency. J Assist Reprod Genet 2017; 34(3): 315–323
https://doi.org/10.1007/s10815-016-0854-6
pmid: 27995424
|
241 |
R Rossetti, I Ferrari, M Bonomi, L Persani. Genetics of primary ovarian insufficiency. Clin Genet 2017; 91(2): 183–198
https://doi.org/10.1111/cge.12921
pmid: 27861765
|
242 |
A Stavljenić-Rukavina. 1. Prenatal diagnosis of chromosomal disorders—molecular aspects. EJIFCC 2008; 19(1): 2–6
pmid: 27683284
|
243 |
RL Bennett. The family medical history as a tool in preconception consultation. J Community Genet 2012; 3(3): 175–183
https://doi.org/10.1007/s12687-012-0107-z
pmid: 22810887
|
244 |
IB Mathijssen, KCA Holtkamp, CPE Ottenheim, JMC van Eeten-Nijman, P Lakeman, H Meijers-Heijboer, MC van Maarle, L Henneman. Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population. Eur J Hum Genet 2018; 26(2): 166–175
https://doi.org/10.1038/s41431-017-0056-4
pmid: 29321671
|
245 |
E Dorney, KI Black. Preconception care. Aust J Gen Pract 2018; 47(7): 424–429
https://doi.org/10.31128/AJGP-02-18-4485
pmid: 30114868
|
246 |
A Elce, A Boccia, G Cardillo, S Giordano, R Tomaiuolo, G Paolella, G Castaldo. Three novel CFTR polymorphic repeats improve segregation analysis for cystic fibrosis. Clin Chem 2009; 55(7): 1372–1379
https://doi.org/10.1373/clinchem.2008.119545
pmid: 19443567
|
247 |
F Cariati, M Savarese, V D’Argenio, F Salvatore, R Tomaiuolo. The SEeMORE strategy: single-tube electrophoresis analysis-based genotyping to detect monogenic diseases rapidly and effectively from conception until birth. Clin Chem Lab Med 2017; 56(1): 40–50
https://doi.org/10.1515/cclm-2017-0147
pmid: 28787268
|
248 |
M Allyse, MA Minear, E Berson, S Sridhar, M Rote, A Hung, S Chandrasekharan. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health 2015; 7: 113–126
https://doi.org/10.2147/IJWH.S67124
pmid: 25653560
|
249 |
EKL Chiu, WWI Hui, RWK Chiu. cfDNA screening and diagnosis of monogenic disorders—where are we heading?. Prenat Diagn 2018; 38(1): 52–58
https://doi.org/10.1002/pd.5207
pmid: 29314147
|
250 |
L Saba, M Masala, V Capponi, G Marceddu, M Massidda, MC Rosatelli. Non-invasive prenatal diagnosis of beta-thalassemia by semiconductor sequencing: a feasibility study in the sardinian population. Eur J Hum Genet 2017; 25(5): 600–607
https://doi.org/10.1038/ejhg.2017.26
pmid: 28272531
|
251 |
MI New, YK Tong, T Yuen, P Jiang, C Pina, KC Chan, A Khattab, GJ Liao, M Yau, SM Kim, RW Chiu, L Sun, M Zaidi, YM Lo. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab 2014; 99(6): E1022–E1030
https://doi.org/10.1210/jc.2014-1118
pmid: 24606108
|
252 |
MK Haahr, CH Jensen, NM Toyserkani, DC Andersen, P Damkier, JA Sørensen, L Lund, SP Sheikh. Safety and potential effect of a single intracavernous injection of autologous adipose-derived regenerative cells in patients with erectile dysfunction following radical prostatectomy: an open-label phase I clinical trial. EBioMedicine 2016; 5: 204–210
https://doi.org/10.1016/j.ebiom.2016.01.024
pmid: 27077129
|
253 |
M Mashayekhi, E Mirzadeh, Z Chekini, F Ahmadi, P Eftekhari-Yazdi, S Vesali, T Madani, N Aghdami. Evaluation of safety, feasibility and efficacy of intra-ovarian transplantation of autologous adipose derived mesenchymal stromal cells in idiopathic premature ovarian failure patients: non-randomized clinical trial, phase I, first in human. J Ovarian Res 2021; 14(1): 5
https://doi.org/10.1186/s13048-020-00743-3
pmid: 33407794
|
254 |
P Igboeli, A El Andaloussi, U Sheikh, H Takala, A ElSharoud, A McHugh, L Gavrilova-Jordan, S Levy, A Al-Hendy. Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature. J Med Case Reports 2020; 14(1): 108
https://doi.org/10.1186/s13256-020-02426-5
pmid: 32680541
|
255 |
YC Cheng, M Takagi, A Milbourne, RE Champlin, NT Ueno. Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients. Oncologist 2012; 17(2): 233–238
https://doi.org/10.1634/theoncologist.2011-0205
pmid: 22282904
|
256 |
Y Cao, H Sun, H Zhu, X Zhu, X Tang, G Yan, J Wang, D Bai, J Wang, L Wang, Q Zhou, H Wang, C Dai, L Ding, B Xu, Y Zhou, J Hao, J Dai, Y Hu. Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: a phase I clinical trial. Stem Cell Res Ther 2018; 9(1): 192
https://doi.org/10.1186/s13287-018-0904-3
pmid: 29996892
|
257 |
W Yang, J Zhang, B Xu, Y He, W Liu, J Li, S Zhang, X Lin, D Su, T Wu, J Li. HucMSC-derived exosomes mitigate the age-related retardation of fertility in female mice. Mol Ther 2020; 28(4): 1200–1213
https://doi.org/10.1016/j.ymthe.2020.02.003
pmid: 32097602
|
258 |
M Spinosa, G Lu, G Su, SV Bontha, R Gehrau, MD Salmon, JR Smith, ML Weiss, VR Mas, GR Jr Upchurch, AK Sharma. Human mesenchymal stromal cell-derived extracellular vesicles attenuate aortic aneurysm formation and macrophage activation via microRNA-147. FASEB J 2018; 32(11): 6038–6050
https://doi.org/10.1096/fj.201701138RR
pmid: 29812968
|
259 |
C Lo Sicco, D Reverberi, C Balbi, V Ulivi, E Principi, L Pascucci, P Becherini, MC Bosco, L Varesio, C Franzin, M Pozzobon, R Cancedda, R Tasso. Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: endorsement of macrophage polarization. Stem Cells Transl Med 2017; 6(3): 1018–1028
https://doi.org/10.1002/sctm.16-0363
pmid: 28186708
|
260 |
C Ding, L Zhu, H Shen, J Lu, Q Zou, C Huang, H Li, B Huang. Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7. Stem Cells 2020; 38(9): 1137–1148
https://doi.org/10.1002/stem.3204
pmid: 32442343
|
261 |
V Bodart-Santos, LRP de Carvalho, MA de Godoy, AF Batista, LM Saraiva, LG Lima, CA Abreu, FG De Felice, A Galina, R Mendez-Otero, ST Ferreira. Extracellular vesicles derived from human Wharton’s jelly mesenchymal stem cells protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers. Stem Cell Res Ther 2019; 10(1): 332
https://doi.org/10.1186/s13287-019-1432-5
pmid: 31747944
|
262 |
S Chaubey, S Thueson, D Ponnalagu, MA Alam, CP Gheorghe, Z Aghai, H Singh, V Bhandari. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6. Stem Cell Res Ther 2018; 9(1): 173
https://doi.org/10.1186/s13287-018-0903-4
pmid: 29941022
|
263 |
C Yang, W Lim, J Park, S Park, S You, G Song. Anti-inflammatory effects of mesenchymal stem cell-derived exosomal microRNA-146a-5p and microRNA-548e-5p on human trophoblast cells. Mol Hum Reprod 2019; 25(11): 755–771
https://doi.org/10.1093/molehr/gaz054
pmid: 31588496
|
264 |
D Ti, H Hao, C Tong, J Liu, L Dong, J Zheng, Y Zhao, H Liu, X Fu, W Han. LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b. J Transl Med 2015; 13(1): 308
https://doi.org/10.1186/s12967-015-0642-6
pmid: 26386558
|
265 |
MA Alzubi, SS Sohal, M Sriram, TH Turner, P Zot, M Idowu, JC Harrell. Quantitative assessment of breast cancer liver metastasis expansion with patient-derived xenografts. Clin Exp Metastasis 2019; 36(3): 257–269
https://doi.org/10.1007/s10585-019-09968-z
pmid: 31069566
|
266 |
JD Anderson, HJ Johansson, CS Graham, M Vesterlund, MT Pham, CS Bramlett, EN Montgomery, MS Mellema, RL Bardini, Z Contreras, M Hoon, G Bauer, KD Fink, B Fury, KJ Hendrix, F Chedin, S El-Andaloussi, B Hwang, MS Mulligan, J Lehtiö, JA Nolta. Comprehensive proteomic analysis of mesenchymal stem cell exosomes reveals modulation of angiogenesis via nuclear factor-kappaB signaling. Stem Cells 2016; 34(3): 601–613
https://doi.org/10.1002/stem.2298
pmid: 26782178
|
267 |
T Lopatina, S Bruno, C Tetta, N Kalinina, M Porta, G Camussi. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun Signal 2014; 12(1): 26
https://doi.org/10.1186/1478-811X-12-26
pmid: 24725987
|
268 |
KS Park, K Svennerholm, GV Shelke, E Bandeira, C Lässer, SC Jang, R Chandode, I Gribonika, J Lötvall. Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10. Stem Cell Res Ther 2019; 10(1): 231
https://doi.org/10.1186/s13287-019-1352-4
pmid: 31370884
|
269 |
H Gonzalez-King, NA García, I Ontoria-Oviedo, M Ciria, JA Montero, P Sepúlveda. Hypoxia inducible factor-1α potentiates jagged 1-mediated angiogenesis by mesenchymal stem cell-derived exosomes. Stem Cells 2017; 35(7): 1747–1759
https://doi.org/10.1002/stem.2618
pmid: 28376567
|
270 |
M Gong, B Yu, J Wang, Y Wang, M Liu, C Paul, RW Millard, DS Xiao, M Ashraf, M Xu. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget 2017; 8(28): 45200–45212
https://doi.org/10.18632/oncotarget.16778
pmid: 28423355
|
271 |
B Zhang, M Wang, A Gong, X Zhang, X Wu, Y Zhu, H Shi, L Wu, W Zhu, H Qian, W Xu. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells 2015; 33(7): 2158–2168
https://doi.org/10.1002/stem.1771
pmid: 24964196
|
272 |
G Baek, H Choi, Y Kim, HC Lee, C Choi. Mesenchymal stem cell-derived extracellular vesicles as therapeutics and as a drug delivery platform. Stem Cells Transl Med 2019; 8(9): 880–886
https://doi.org/10.1002/sctm.18-0226
pmid: 31045328
|
273 |
L Liu, Y Liu, C Feng, J Chang, R Fu, T Wu, F Yu, X Wang, L Xia, C Wu, B Fang. Lithium-containing biomaterials stimulate bone marrow stromal cell-derived exosomal miR-130a secretion to promote angiogenesis. Biomaterials 2019; 192: 523–536
https://doi.org/10.1016/j.biomaterials.2018.11.007
pmid: 30529871
|
274 |
M Yang, L Lin, C Sha, T Li, D Zhao, H Wei, Q Chen, Y Liu, X Chen, W Xu, Y Li, X Zhu. Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN. Lab Invest 2020; 100(3): 342–352
https://doi.org/10.1038/s41374-019-0321-y
pmid: 31537899
|
275 |
J Zhao, X Li, J Hu, F Chen, S Qiao, X Sun, L Gao, J Xie, B Xu. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischaemia-reperfusion injury through miR-182-regulated macrophage polarization. Cardiovasc Res 2019; 115(7): 1205–1216
https://doi.org/10.1093/cvr/cvz040
pmid: 30753344
|
276 |
A Eirin, XY Zhu, AS Puranik, JR Woollard, H Tang, S Dasari, A Lerman, AJ van Wijnen, LO Lerman. Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem/stromal cells. Sci Rep 2016; 6(1): 36120
https://doi.org/10.1038/srep36120
pmid: 27786293
|
277 |
KR Vrijsen, JA Maring, SA Chamuleau, V Verhage, EA Mol, JC Deddens, CH Metz, K Lodder, EC van Eeuwijk, SM van Dommelen, PA Doevendans, AM Smits, MJ Goumans, JP Sluijter. Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis via EMMPRIN. Adv Healthc Mater 2016; 5(19): 2555–2565
https://doi.org/10.1002/adhm.201600308
pmid: 27570124
|
278 |
SK Crain, SR Robinson, KE Thane, AM Davis, DM Meola, BA Barton, VK Yang, AM Hoffman. Extracellular vesicles from Wharton’s jelly mesenchymal stem cells suppress CD4 expressing T cells through transforming growth factor beta and adenosine signaling in a canine model. Stem Cells Dev 2019; 28(3): 212–226
https://doi.org/10.1089/scd.2018.0097
pmid: 30412034
|
279 |
S Mardpour, AA Hamidieh, S Taleahmad, F Sharifzad, A Taghikhani, H Baharvand. Interaction between mesenchymal stromal cell-derived extracellular vesicles and immune cells by distinct protein content. J Cell Physiol 2019; 234(6): 8249–8258
https://doi.org/10.1002/jcp.27669
pmid: 30378105
|
280 |
C Merino-González, FA Zuñiga, C Escudero, V Ormazabal, C Reyes, E Nova-Lamperti, C Salomón, C Aguayo. Mesenchymal stem cell-derived extracellular vesicles promote angiogenesis: potencial clinical application. Front Physiol 2016; 7: 24
https://doi.org/10.3389/fphys.2016.00024
pmid: 26903875
|
281 |
K Tsuji, S Kitamura, J Wada. Immunomodulatory and regenerative effects of mesenchymal stem cell-derived extracellular vesicles in renal diseases. Int J Mol Sci 2020; 21(3): 756
https://doi.org/10.3390/ijms21030756
pmid: 31979395
|
282 |
F Paduano, M Marrelli, F Palmieri, M Tatullo. CD146 expression influences periapical cyst mesenchymal stem cell properties. Stem Cell Rev Rep 2016; 12(5): 592–603
https://doi.org/10.1007/s12015-016-9674-4
pmid: 27406247
|
283 |
T Momose, H Miyaji, A Kato, K Ogawa, T Yoshida, E Nishida, S Murakami, Y Kosen, T Sugaya, M Kawanami. Collagen hydrogel scaffold and fibroblast growth factor-2 accelerate periodontal healing of class II furcation defects in dog. Open Dent J 2016; 10(1): 347–359
https://doi.org/10.2174/1874210601610010347
pmid: 27583044
|
284 |
I Cervelló, C Gil-Sanchis, X Santamaría, S Cabanillas, A Díaz, A Faus, A Pellicer, C Simón. Human CD133(+) bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome. Fertil Steril 2015; 104(6): 1552–60.e1-3
https://doi.org/10.1016/j.fertnstert.2015.08.032
pmid: 26384164
|
285 |
SA Mohamed, SM Shalaby, M Abdelaziz, S Brakta, WD Hill, N Ismail, A Al-Hendy. Human mesenchymal stem cells partially reverse infertility in chemotherapy-induced ovarian failure. Reprod Sci 2018; 25(1): 51–63
https://doi.org/10.1177/1933719117699705
pmid: 28460567
|
286 |
SH Abd-Allah, SM Shalaby, HF Pasha, AS El-Shal, N Raafat, SM Shabrawy, HA Awad, MG Amer, MA Gharib, EA El Gendy, AA Raslan, HM El-Kelawy. Mechanistic action of mesenchymal stem cell injection in the treatment of chemically induced ovarian failure in rabbits. Cytotherapy 2013; 15(1): 64–75
https://doi.org/10.1016/j.jcyt.2012.08.001
pmid: 23260087
|
287 |
D Fan, S Wu, S Ye, W Wang, X Guo, Z Liu. Umbilical cord mesenchyme stem cell local intramuscular injection for treatment of uterine niche: protocol for a prospective, randomized, double-blinded, placebo-controlled clinical trial. Medicine (Baltimore) 2017; 96(44): e8480
https://doi.org/10.1097/MD.0000000000008480
pmid: 29095305
|
288 |
J Li, Q Mao, J He, H She, Z Zhang, C Yin. Human umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism. Stem Cell Res Ther 2017; 8(1): 55
https://doi.org/10.1186/s13287-017-0514-5
pmid: 28279229
|
289 |
S Wang, L Yu, M Sun, S Mu, C Wang, D Wang, Y Yao. The therapeutic potential of umbilical cord mesenchymal stem cells in mice premature ovarian failure. Biomed Res Int 2013; 2013: 690491
https://doi.org/10.1155/2013/690491
pmid: 23998127
|
290 |
S Kilic, B Yuksel, F Pinarli, A Albayrak, B Boztok, T Delibasi. Effect of stem cell application on Asherman syndrome, an experimental rat model. J Assist Reprod Genet 2014; 31(8): 975–982
https://doi.org/10.1007/s10815-014-0268-2
pmid: 24974357
|
291 |
J Su, L Ding, J Cheng, J Yang, X Li, G Yan, H Sun, J Dai, Y Hu. Transplantation of adipose-derived stem cells combined with collagen scaffolds restores ovarian function in a rat model of premature ovarian insufficiency. Hum Reprod 2016; 31(5): 1075–1086
https://doi.org/10.1093/humrep/dew041
pmid: 26965432
|
292 |
P Terraciano, T Garcez, L Ayres, I Durli, M Baggio, CP Kuhl, C Laurino, E Passos, AH Paz, E Cirne-Lima. Cell therapy for chemically induced ovarian failure in mice. Stem Cells Int 2014; 2014: 720753
https://doi.org/10.1155/2014/720753
pmid: 25548574
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|